A life-saving prostate cancer medication that once cost Aussie men up to $930 per script has now been added to the Pharmaceutical Benefits Scheme, slashing the price to just $25 — or $7.70 with a concession card.
The drug, Andriga-10, hasn’t changed. The treatment hasn’t changed.
Only the bill has — and for many men, that could be the difference between getting treatment or putting it off.
Health experts say high costs have forced too many men to delay care, despite prostate cancer affecting 1 in 5 Australian men. Early treatment can be life-changing, even life-saving.
With the new PBS listing, more men can now access the medication without the financial stress that has hit families for years.
Cheaper medicines mean earlier treatment, better outcomes, and fewer households choosing between their health and their bank balance.
If you’ve got a dad, brother, mate or workmate — this is worth sharing.
Because saving lives shouldn’t come with a $930 price tag.